Electromed, Inc.

Electromed, Inc.

Founded in 1992 and headquartered in New Prague, Minnesota, Electromed develops, manufactures, and markets airway clearance technologies. The company has been publicly traded on the NYSE American exchange under the ticker ELMD since its listing, operating as a specialized medical device firm rather than a traditional asset manager or family office. The company's core product is the SmartVest system, a high-frequency chest wall oscillation (HFCWO) therapy device. It uses an inflatable vest connected to an air-pulse generator to loosen and mobilize mucus in patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions. Electromed distributes directly to patients through a dedicated reimbursement and clinical support team, handling insurance verification, billing, and ongoing patient care coordination across the United States. Electromed maintains a lean operational profile. As a reporting public company, its financials and team size are disclosed in SEC filings. CEO Kathleen Skarvan has led the firm through a period focused on expanding clinical evidence, including published studies on HFCWO efficacy. The company operates from a single headquarters in New Prague, serving patients nationwide through a direct-to-consumer sales model supported by physician prescriptions and durable medical equipment (DME) billing codes. Structurally, Electromed is distinct: it is neither a contract manufacturer nor a diversified med-tech conglomerate. It is a single-product, patient-facing public company with its own reimbursement infrastructure, essentially operating a vertically integrated supply chain from manufacturing to insurance billing for durable medical equipment. This direct patient-service arm is a meaningful differentiator in the HFCWO market.